Bicycle Total Current Liabilities vs Cash And Short Term Investments Analysis
BCYC Stock | USD 21.36 0.82 3.70% |
Bicycle Therapeutics financial indicator trend analysis is way more than just evaluating Bicycle Therapeutics prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Bicycle Therapeutics is a good investment. Please check the relationship between Bicycle Therapeutics Total Current Liabilities and its Cash And Short Term Investments accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bicycle Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in manufacturing. For information on how to trade Bicycle Stock refer to our How to Trade Bicycle Stock guide.
Total Current Liabilities vs Cash And Short Term Investments
Total Current Liabilities vs Cash And Short Term Investments Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Bicycle Therapeutics Total Current Liabilities account and Cash And Short Term Investments. At this time, the significance of the direction appears to have almost identical trend.
The correlation between Bicycle Therapeutics' Total Current Liabilities and Cash And Short Term Investments is 0.97. Overlapping area represents the amount of variation of Total Current Liabilities that can explain the historical movement of Cash And Short Term Investments in the same time period over historical financial statements of Bicycle Therapeutics, assuming nothing else is changed. The correlation between historical values of Bicycle Therapeutics' Total Current Liabilities and Cash And Short Term Investments is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Current Liabilities of Bicycle Therapeutics are associated (or correlated) with its Cash And Short Term Investments. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Cash And Short Term Investments has no effect on the direction of Total Current Liabilities i.e., Bicycle Therapeutics' Total Current Liabilities and Cash And Short Term Investments go up and down completely randomly.
Correlation Coefficient | 0.97 |
Relationship Direction | Positive |
Relationship Strength | Very Strong |
Total Current Liabilities
Total Current Liabilities is an item on Bicycle Therapeutics balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Bicycle Therapeutics are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.Cash And Short Term Investments
Short Term Investments is an account in the current assets section of Bicycle Therapeutics balance sheet. This account contains Bicycle Therapeutics investments that will expire within one year. These investments include stocks and bonds that can be liquidated by Bicycle Therapeutics fairly quickly. The sum of a company's cash on hand, including bank deposits and short-term, highly liquid investments that are easily convertible to known amounts of cash.Most indicators from Bicycle Therapeutics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Bicycle Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bicycle Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in manufacturing. For information on how to trade Bicycle Stock refer to our How to Trade Bicycle Stock guide.At present, Bicycle Therapeutics' Selling General Administrative is projected to increase significantly based on the last few years of reporting. The current year's Issuance Of Capital Stock is expected to grow to about 267.8 M, whereas Sales General And Administrative To Revenue is forecasted to decline to 1.89.
Bicycle Therapeutics fundamental ratios Correlations
Click cells to compare fundamentals
Bicycle Therapeutics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Bicycle Therapeutics fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 110.2M | 161.2M | 479.8M | 410.6M | 595.3M | 625.1M | |
Other Current Liab | 5.5M | 10.8M | 11.9M | 23.3M | 26.6M | 28.0M | |
Total Current Liabilities | 8.8M | 23.1M | 36.2M | 53.3M | 69.5M | 73.0M | |
Total Stockholder Equity | 93.2M | 95.5M | 346.3M | 270.8M | 370.9M | 389.5M | |
Other Liab | 6.9M | 27.6M | 55.3M | 45.3M | 52.1M | 26.8M | |
Net Tangible Assets | 93.2M | 95.5M | 346.3M | 270.8M | 311.4M | 327.0M | |
Retained Earnings | (100.6M) | (151.6M) | (218.4M) | (331.1M) | (511.8M) | (486.2M) | |
Accounts Payable | 1.9M | 1.4M | 2.7M | 6.5M | 13.1M | 13.7M | |
Cash | 92.1M | 136.0M | 438.7M | 339.2M | 526.4M | 552.7M | |
Other Assets | 1.7M | 3.1M | 3.4M | 8.5M | 9.7M | 10.2M | |
Cash And Short Term Investments | 92.1M | 136.0M | 438.7M | 339.2M | 526.4M | 552.7M | |
Net Receivables | 7.1M | 14.6M | 11.9M | 21.2M | 24.0M | 13.0M | |
Common Stock Total Equity | 5K | 10K | 227K | 266K | 305.9K | 321.2K | |
Other Current Assets | 4.9M | 5.1M | 8.0M | 9.0M | 11.4M | 12.0M | |
Other Stockholder Equity | 195.1M | 249.9M | 567.6M | 601.1M | 883.4M | 927.6M | |
Total Liab | 17.0M | 65.7M | 133.5M | 139.8M | 224.4M | 117.8M | |
Total Current Assets | 104.1M | 155.7M | 458.6M | 369.4M | 561.9M | 590.0M | |
Accumulated Other Comprehensive Income | (1.5M) | (3.2M) | (3.4M) | 387K | (1.3M) | (1.4M) | |
Short Term Debt | 640K | 844K | 2.4M | 3.1M | 4.9M | 5.1M | |
Common Stock | 227K | 266K | 384K | 387K | 550K | 577.5K | |
Property Plant Equipment | 4.3M | 3.6M | 17.8M | 32.8M | 37.7M | 39.6M | |
Property Plant And Equipment Net | 4.3M | 3.6M | 17.8M | 32.8M | 27.7M | 14.0M | |
Current Deferred Revenue | 728K | 10.1M | 19.3M | 20.4M | 25.0M | 12.5M | |
Net Debt | (90.2M) | (120.2M) | (394.3M) | (294.8M) | (481.5M) | (457.4M) | |
Non Current Assets Total | 6.0M | 5.4M | 21.2M | 41.2M | 33.5M | 18.0M | |
Non Currrent Assets Other | 1.7M | 1.8M | 3.4M | 8.5M | 5.2M | 3.9M | |
Common Stock Shares Outstanding | 11.0M | 19.1M | 25.1M | 29.7M | 35.6M | 23.1M | |
Liabilities And Stockholders Equity | 110.2M | 161.2M | 479.8M | 410.6M | 595.3M | 300.6M | |
Non Current Liabilities Total | 8.2M | 42.6M | 97.3M | 86.5M | 154.9M | 101.1M | |
Net Invested Capital | 93.2M | 110.0M | 376.1M | 301.1M | 401.6M | 421.7M | |
Property Plant And Equipment Gross | 4.3M | 3.6M | 22.6M | 40.6M | 41.1M | 43.1M | |
Non Current Liabilities Other | 2.0M | 2.6M | 3.3M | 3.8M | 4.6M | 2.8M | |
Net Working Capital | 95.3M | 132.6M | 422.3M | 316.0M | 492.3M | 249.6M | |
Capital Stock | 227K | 266K | 384K | 387K | 550K | 334.4K |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.C | Citigroup | |
CRM | Salesforce | |
MSFT | Microsoft |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bicycle Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in manufacturing. For information on how to trade Bicycle Stock refer to our How to Trade Bicycle Stock guide.You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Complementary Tools for Bicycle Stock analysis
When running Bicycle Therapeutics' price analysis, check to measure Bicycle Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bicycle Therapeutics is operating at the current time. Most of Bicycle Therapeutics' value examination focuses on studying past and present price action to predict the probability of Bicycle Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bicycle Therapeutics' price. Additionally, you may evaluate how the addition of Bicycle Therapeutics to your portfolios can decrease your overall portfolio volatility.
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |
Is Bicycle Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bicycle Therapeutics. If investors know Bicycle will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bicycle Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (4.40) | Revenue Per Share 1.074 | Quarterly Revenue Growth 2.989 | Return On Assets (0.23) | Return On Equity (0.56) |
The market value of Bicycle Therapeutics is measured differently than its book value, which is the value of Bicycle that is recorded on the company's balance sheet. Investors also form their own opinion of Bicycle Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Bicycle Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bicycle Therapeutics' market value can be influenced by many factors that don't directly affect Bicycle Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bicycle Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Bicycle Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bicycle Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.